gms | German Medical Science

15th Annual Meeting of the German Drug Utilisation Research Group (GAA)

Gesellschaft für Arzneimittelforschung und Arzneimittelepidemiologie

20.11. - 21.11.2008, Bonn

Pharmacovigilance and risk management

Meeting Abstract (08gaa10)

Identification of drugs causing Blood Dyscrasias, Hepatitis and Pancreatitis – Outcomes of the Case-Control Surveillance Study from the National Pharmacovigilance-Center Berlin (PVZ-FAKOS)

Thomae M, Bronder E, Andersohn F, Klimpel A, Garbe E
[Full Text]
Meeting Abstract (08gaa11)

Sex-differences in the rate of adverse drug reactions associated with diuretics

Thürmann P, Janhsen K, Werner U, Szymanski J, Müller S, Drewelow B, Farker K, Hippius M, Siegmund W, May K, Glaeske G, Rottenkolber M, Hasford J
[Full Text]
Meeting Abstract (08gaa12)

Pharmacovigilance and Patient Safety – Results of the German Net of Regional Pharmacovigilance Centers

Schmiedl S, Hasford J, Rottenkolber M, Szymanski J, Drewelow B, Mueller S, Haase G, Siegmund W, May H, Hippius M, Farker K, Gruca D, Guenther IR, Thuermann PA
[Full Text]
Meeting Abstract (08gaa13)

Signal generation in the database of the German Net of Regional Pharmacovigilance Centers

Rottenkolber M, Hasford J
[Full Text]
Meeting Abstract (08gaa14)

Adverse drug reactions and potentially inappropriate medication for the elderly

Thürmann PA, Rottenkolber M, Schmiedl S, Müller S, Drewelow B, Farker K, Hippius M, Siegmund W, May K, Hasford J
[Full Text]
Meeting Abstract (08gaa15)

Educational Intervention and Monitoring Programme to Improve Physician Reporting of Adverse Drug Reactions (ADRs) in a Primary Care Setting

Tabali M, Jeschke E, Bockelbrink A, Witt CM, Willich SN, Ostermann T, Matthes H
[Full Text]
Meeting Abstract (08gaa16)

Impact of risk communications and market withdrawals on prescribing of cyclooxygenase-2 inhibitors and non-selective nonsteroidal anti-inflammatory drugs

Czeche S, Quinzler R, Schüssel K, Feldt S, Klöckner D, Schulz M
[Full Text]